News
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
April 16 (UPI) -- Target has recalled 25,600 tubs of Good & Gather baby food because of elevated lead levels. The retailer on ...
HHS denied censoring Dr. Kevin Hall, the researcher who announced his early retirement on Wednesday, saying it was a ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...
President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback